Figure S5 from DSP502 Combines Dual Inhibition of PD-L1 and PVR to Trigger Anticancer Immune Responses

<jats:p>&lt;p&gt;Figure S5. Expression of DNAM-1 in T and NK cells and CD25 expressions in T and NK cells with or without DSP502 treatment co-cultured with ES-2.WT, ES-2.PD-L1&lt;sup&gt;KO&lt;/sup&gt;, ES-2.PVR&lt;sup&gt;KO,&lt;/sup&gt; or ES-2.PVR/PD-L1&lt;sup&gt;KO&lt;/sup&gt;.&lt;/p&gt;</jats:p>